| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,656 |
8,331 |
$1.05M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,590 |
11,221 |
$985K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,473 |
2,371 |
$398K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,994 |
1,923 |
$213K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
739 |
714 |
$130K |
| G0378 |
Hospital observation service, per hour |
120 |
111 |
$112K |
| 80053 |
Comprehensive metabolic panel |
9,658 |
9,209 |
$98K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,225 |
1,143 |
$84K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,677 |
1,624 |
$68K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,732 |
11,163 |
$63K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,388 |
1,356 |
$47K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,515 |
4,275 |
$45K |
| X0620 |
|
171 |
147 |
$42K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
434 |
421 |
$33K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
45 |
45 |
$30K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
147 |
142 |
$30K |
| 70450 |
Computed tomography, head or brain; without contrast material |
434 |
420 |
$27K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
257 |
247 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
2,533 |
2,405 |
$18K |
| 87631 |
|
99 |
97 |
$16K |
| 83605 |
|
2,089 |
1,982 |
$14K |
| 83690 |
|
3,077 |
2,939 |
$14K |
| 83880 |
|
448 |
424 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
182 |
172 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
763 |
738 |
$10K |
| 84484 |
|
1,088 |
1,008 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,043 |
994 |
$8K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
13 |
13 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
996 |
945 |
$7K |
| 83735 |
|
1,066 |
1,019 |
$7K |
| 85730 |
|
1,144 |
1,107 |
$7K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
88 |
87 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
407 |
398 |
$6K |
| 81001 |
|
1,940 |
1,858 |
$5K |
| 85610 |
|
1,528 |
1,469 |
$5K |
| 73630 |
|
361 |
299 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
40 |
40 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
55 |
54 |
$4K |
| 87070 |
|
465 |
434 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
158 |
158 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
155 |
151 |
$3K |
| 73610 |
|
188 |
167 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,896 |
1,806 |
$3K |
| 85379 |
|
304 |
293 |
$3K |
| 93971 |
|
43 |
41 |
$3K |
| 87040 |
|
130 |
127 |
$2K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
27 |
27 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
267 |
259 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
46 |
46 |
$2K |
| 81003 |
|
596 |
573 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
31 |
27 |
$2K |
| 84703 |
|
124 |
117 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
701 |
607 |
$1K |
| 73564 |
|
60 |
51 |
$1K |
| 82550 |
|
193 |
185 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
31 |
28 |
$911.52 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
14 |
13 |
$891.50 |
| 73030 |
|
55 |
51 |
$711.79 |
| 76000 |
|
55 |
39 |
$650.17 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
17 |
17 |
$645.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
27 |
27 |
$575.70 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,717 |
4,264 |
$555.93 |
| 72100 |
|
25 |
25 |
$541.90 |
| 80050 |
General health panel |
13 |
13 |
$526.68 |
| 84702 |
|
29 |
26 |
$509.38 |
| 85027 |
|
66 |
64 |
$420.36 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
455 |
389 |
$409.16 |
| 82948 |
|
215 |
201 |
$378.89 |
| 86140 |
|
152 |
144 |
$348.03 |
| 76642 |
|
12 |
12 |
$337.32 |
| 73502 |
|
14 |
14 |
$252.32 |
| 36415 |
Collection of venous blood by venipuncture |
640 |
564 |
$248.34 |
| 73110 |
|
17 |
16 |
$193.68 |
| 73130 |
|
14 |
13 |
$146.35 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,265 |
1,188 |
$137.24 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,190 |
2,913 |
$109.25 |
| 84100 |
|
15 |
13 |
$106.51 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
85 |
80 |
$100.00 |
| 82553 |
|
12 |
12 |
$93.31 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
764 |
717 |
$91.34 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
694 |
634 |
$71.05 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
90 |
80 |
$69.02 |
| 85652 |
|
13 |
13 |
$36.24 |
| J2060 |
Injection, lorazepam, 2 mg |
71 |
63 |
$11.26 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
213 |
200 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
12 |
12 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
24 |
24 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
39 |
32 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
31 |
28 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
569 |
483 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
36 |
32 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
587 |
537 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
13 |
12 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
127 |
125 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
35 |
30 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
17 |
17 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
40 |
33 |
$0.00 |
| A9270 |
Non-covered item or service |
13 |
13 |
$0.00 |